• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493918424300
Device Problem Occlusion Within Device (1423)
Patient Problems Cardiac Arrest (1762); Chest Pain (1776); Death (1802); Thrombosis (2100); Ventricular Tachycardia (2132); Obstruction/Occlusion (2422)
Event Date 07/02/2017
Event Type  Death  
Manufacturer Narrative
Age at time of event: 18 years or older.Device is a combination product.Device evaluated by mfr: the device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2017-07184.It was reported that plaque shift, stent thrombosis, cardiac arrest occurred and the patient died.Vascular access was obtained via the femoral artery.The 95% stenosed, 3x18mm, concentric, de novo target lesion was located in the non-tortuous and moderately calcified ostial left anterior descending artery (lad).Following predilitation, a 3.00x24mm promus element plus drug-eluting stent was successfully implanted in the lad and post dilated.Post deployment, it was noted that there was a plaque shift to left circumflex artery (lcx).A 2.50 x 24mm synergy drug-eluting stent was implanted in the lcx.It was also noted that stent thrombosis occurred and the patient had cardiac arrest.Kissing balloon technique was performed and the procedure was completed.However, the patient died while in the icu.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that in the intensive care unit (icu), the patient developed severe chest pain followed by ventricular tachycardia.The official cause of death was cardiac arrest.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6719453
MDR Text Key80220021
Report Number2134265-2017-07213
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/17/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/20/2018
Device Model NumberH7493918424300
Device Catalogue Number39184-2430
Device Lot Number19894550
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/09/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-